Epstein Secrets

cash flows for its capital owners. Any future sale or transaction is expected to be based on the Company's future cash flow expectations. As such, the Income Approach was the primary methodology used in arriving at a value for the Company's equity. Please see Exhibits F and G for further details related to our an

0 Comma narrnils 639098 027800 0.19033 173 639 Comma namnIs 100800 0.34000 003971 36 100 Comemn isorrom 50=0 0.51000 002978 27 50 HO Rae Comma &moots 506298 5,027927 5253 907 ZOtSonte Wcieltal SOX Comecon ovum 705.737 1400500 5080031 SI 706 Comermcopoun - 000550 4102000 0 Commmopt

cash flows for its capital owners. Any future sale or transaction is expected to be based on the Company's future cash flow expectations. As such, the Income Approach was the primary methodology used in arriving at a value for the Company's equity. Please see Exhibits F and G for further details related to our an

0 Comma narrnils 639098 027800 0.19033 173 639 Comma namnIs 100800 0.34000 003971 36 100 Comemn isorrom 50=0 0.51000 002978 27 50 HO Rae Comma &moots 506298 5,027927 5253 907 ZOtSonte Wcieltal SOX Comecon ovum 705.737 1400500 5080031 SI 706 Comermcopoun - 000550 4102000 0 Commmopt

cash flows for its capital owners. Any future sale or transaction is expected to be based on the Company's future cash flow expectations. As such, the Income Approach was the primary methodology used in arriving at a value for the Company's equity. Please see Exhibits F and G for further details related to our an

0 Comma narrnils 639098 027800 0.19033 173 639 Comma namnIs 100800 0.34000 003971 36 100 Comemn isorrom 50=0 0.51000 002978 27 50 HO Rae Comma &moots 506298 5,027927 5253 907 ZOtSonte Wcieltal SOX Comecon ovum 705.737 1400500 5080031 SI 706 Comermcopoun - 000550 4102000 0 Commmopt